4 completed, 3 recruiting, 1 active not recruiting, 1 terminated. 4 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Terminated 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Liver Inflammation: new trials by email Literature Review of Liver Inflammation trials Research Report on Liver Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Non-Invasive Tests for Metabolic Liver Disease Metabolic Associated Fatty Liver Disease, Metabolic Associated Steatotic Liver Disease | Recruiting | Foundation for the National Institutes of Health | 400 | 2025-05-13 | 2026-10-26 | |
| LivQ-box® Parameters in the Diagnosis of Liver Inflammation Liver Inflammation, Fatty Liver Disease | Recruiting | Wuxi Hisky Medical Technology Co Ltd | 365 | 2024-01-01 | 2025-01-31 | |
| Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry Liver Diseases, Liver Neoplasms | Withdrawn | Sheikh Shakhbout Medical City | 2023-04-01 | 2024-11-19 | ||
| Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet, Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet - Hepatitis C, Liver Inflammation | Not applicable | Terminated | Kirby Institute | 21 | 2021-02-12 | 2026-05-26 |
| Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. LIVERFASt - Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis | Not applicable | Completed | Fibronostics USA, Inc | 241 | 2021-01-07 | 2022-08-02 |
| Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis | Completed | University of California, San Diego | 30 | 2019-05-21 | 2024-11-25 | |
| Simplified Monitoring Myanmar SM2 Study HCV point of care machine - Hepatitis C, Liver Cirrhoses | Not applicable | Completed | Kirby Institute | 200 | 2019-01-22 | 2021-02-21 |
| Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B Entecavir, Magnesium Isoglycyrrhizinate, Diammonium Glycyrrhizinate - Chronic Hepatitis b, Liver Inflammation | Phase 4 | Unknown | Cttq | 480 | 2017-11-25 | 2017-11-21 |
| sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis Blood samples, fibroscan and questionaires - Primary Biliary Cirrhosis, Liver Inflammation | Active not recruiting | University of Aarhus | 168 | 2016-09-01 | 2022-08-12 | |
| sCD163 in PBC Patients - Assessment of Treatment Response Blood samples, Fibroscan, Questionnaires - Primary Biliary Cirrhosis, Liver Inflammation | Recruiting | University of Aarhus | 40 | 2016-09-01 | 2022-08-12 | |
| Ultrasound Based Acoustic Radiation Force Impulse Imaging Ultrasound-Based Acoustic Radiation Force Impulse (ARFI) - Liver Fibrosis, Liver Inflammation | Not applicable | Completed | University of Michigan | 62 | 2012-11-01 | 2016-10-21 |
Hepatitis (11) · Liver Cirrhosis (6) · Non-alcoholic Fatty Liver Disease (3) · Fatty Liver (2) · Hepatitis C (2) · Liver Cirrhosis, Biliary (2) · HIV Infections (1) · Hepatitis B, Chronic (1) · Liver Diseases (1) · Liver Failure, Acute (1) · Liver Neoplasms (1)
Digestive System Diseases (11) · Liver Diseases (10) · Fibrosis (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Blood-Borne Infections (3) · Communicable Diseases (3) · Hepatitis, Viral, Human (3) · Infections (3) · Virus Diseases (3) · Bile Duct Diseases (2) · Biliary Tract Diseases (2) · Cholestasis (2) · Cholestasis, Intrahepatic (2) · Fatty Liver (2)
Blood Specimen Collection (2) · 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate (1) · Glycyrrhizic Acid (1) · Sofosbuvir (1) · Surveys and Questionnaires (1) · entecavir (1) · glecaprevir (1) · pibrentasvir (1)
Kirby Institute (2) · University of Aarhus (2) · Cttq (1) · Fibronostics USA, Inc (1) · Foundation for the National Institutes of Health (1) · Sheikh Shakhbout Medical City (1) · University of California, San Diego (1) · University of Michigan (1) · Wuxi Hisky Medical Technology Co Ltd (1)
United States (4) · Australia (2) · Denmark (2) · China (1)
Arun Sanyal (1) · Claude B Sirlin, MD (1) · Imtiaz Alam, MD (1) · Jonathan Dillman, M.D. (1) · Ronald Quiambao, MD (1) · Sven Henrichwark (1)